Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at increased risk of persistent infection. Th...

Source: Annals of Clinical Microbiology and Antimicrobials - December 30, 2021 Category: Microbiology Authors: Yusri Taha, Hayley Wardle, Adam B. Evans, Ewan R. Hunter, Helen Marr, Wendy Osborne, Matthew Bashton, Darren Smith, Shirelle Burton-Fanning, Matthias L. Schmid and Christopher J. A. Duncan Tags: Case report Source Type: research